血浆脑啡肽原与中性粒细胞明胶酶相关脂质运载蛋白对心源性休克急性肾损伤和死亡的预测价值
本研究基于前瞻性CardShock研究154例心源性休克患者,在基线至48小时多个时间点检测血浆脑啡肽原(P-PENK)和中性粒细胞明胶酶相关脂质运载蛋白(P-NGAL)。基线P-PENK>84.8 pmol/mL和P-NGAL>104 ng/mL为预测急性肾损伤的最佳切点,校正后HR分别为2.2和2.8。基线两项标志物均与90天死亡相关;入组前少尿>6小时的患者中,基线P-PENK/P-NGAL低者与高者90天死亡率分别为5% vs 68%。24小时切点P-PENK>105.7 pmol/L和P-NGAL>151 ng/mL对90天死亡的未校正HR分别为5.6和5.2,校正急性肾损伤和两个死亡风险评分后仍显著。
要点
- 心源性休克患者基线P-PENK>84.8 pmol/mL独立预测急性肾损伤(校正HR 2.2,95%CI 1.1-4.4,p=0.03)。
- 基线P-NGAL>104 ng/mL独立预测急性肾损伤(校正HR 2.8,95%CI 1.2-6.5,p=0.01)。
- 入组前少尿<0.5 mL/kg/h持续>6小时者,基线P-PENK/P-NGAL低与高者90天死亡率5% vs 68%(p<0.001)。
- 24小时P-PENK>105.7 pmol/L预测90天死亡未校正HR 5.6(95%CI 3.1-10.7,p<0.001)。
- 24小时P-NGAL>151 ng/mL预测90天死亡未校正HR 5.2(95%CI 2.8-9.8,p<0.001),校正急性肾损伤和两个风险评分后仍显著。
适用人群与场景
- 前瞻性CardShock研究纳入的154例心源性休克患者,平均年龄66岁,26%为女性。
诊断标准与关键阈值
- 急性肾损伤定义:48小时内肌酐升高。
- 急性肾损伤预测最佳切点:基线P-PENK>84.8 pmol/mL、基线P-NGAL>104 ng/mL。
- 90天死亡预测最佳切点:24小时P-PENK>105.7 pmol/L、24小时P-NGAL>151 ng/mL。
- 少尿定义:入组前尿量<0.5 mL/kg/h持续>6小时。
红旗征与不能漏的情况
- 入组前少尿<0.5 mL/kg/h持续>6小时且基线P-PENK/P-NGAL高者,90天死亡率达68%。
研究设计与关键结果
- 研究类型:基于前瞻性CardShock研究(NCT01374867)的分析,纳入154例心源性休克患者,在基线至48小时多个时间点检测P-PENK和P-NGAL。
- 基线P-PENK和P-NGAL中位数(四分位距)分别为99(71-150)pmol/mL和138(84-214)ng/mL。
- 基线P-PENK>84.8 pmol/mL与急性肾损伤独立相关(校正HR 2.2,95%CI 1.1-4.4,p=0.03);基线P-NGAL>104 ng/mL与急性肾损伤独立相关(校正HR 2.8,95%CI 1.2-6.5,p=0.01)。
- 入组前少尿<0.5 mL/kg/h持续>6小时的患者中,基线P-PENK/P-NGAL低者与高者90天死亡率分别为5% vs 68%(p<0.001)。
- 24小时P-PENK>105.7 pmol/L对90天死亡的未校正HR为5.6(95%CI 3.1-10.7,p<0.001);24小时P-NGAL>151 ng/mL的未校正HR为5.2(95%CI 2.8-9.8,p<0.001)。
- 24小时标志物与90天死亡的关联在校正急性肾损伤和两个心源性休克死亡风险评分后仍显著。
证据类型、等级与局限
- 证据类型:基于前瞻性CardShock研究的生物标志物分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在心源性休克患者中,基线P-PENK和P-NGAL高值提示急性肾损伤风险升高,可辅助早期识别高危患者。
- 入组前少尿>6小时的患者,若基线P-PENK/P-NGAL低,90天死亡率仅5%;若高,则达68%,提示需结合生物标志物分层评估预后。
- 24小时P-PENK和P-NGAL高值是90天死亡的强独立预测因素,可用于重症监护中的预后判断。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Acute kidney injury (AKI) is a frequent form of organ injury in cardiogenic shock. However, data on AKI markers such as plasma proenkephalin (P-PENK) and neutrophil gelatinase-associated lipocalin (P-NGAL) in cardiogenic shock populations are lacking. The objective of this study was to assess the ability of P-PENK and P-NGAL to predict acute kidney injury and mortality in cardiogenic shock.
RESULTS: P-PENK and P-NGAL were measured at different time points between baseline and 48 h in 154 patients from the prospective CardShock study. The outcomes assessed were AKI defined by an increase in creatinine within 48 h and all-cause 90-day mortality. Mean age was 66 years and 26% were women. Baseline levels of P-PENK and P-NGAL (median [interquartile range]) were 99 (71-150) pmol/mL and 138 (84-214) ng/mL. P-PENK > 84.8 pmol/mL and P-NGAL > 104 ng/mL at baseline were identified as optimal cut-offs for AKI prediction and independently associated with AKI (adjusted HRs 2.2 [95% CI 1.1-4.4, p = 0.03] and 2.8 [95% CI 1.2-6.5, p = 0.01], respectively). P-PENK and P-NGAL levels at baseline were also associated with 90-day mortality. For patients with oliguria < 0.5 mL/kg/h for > 6 h before study enrollment, 90-day mortality differed significantly between patients with low and high P-PENK/P-NGAL at baseline (5% vs. 68%, p < 0.001). However, the biomarkers provided best discrimination for mortality when measured at 24 h. Identified cut-offs of P-PENK24h > 105.7 pmol/L and P-NGAL24h > 151 ng/mL had unadjusted hazard ratios of 5.6 (95% CI 3.1-10.7, p < 0.001) and 5.2 (95% CI 2.8-9.8, p < 0.001) for 90-day mortality. The association remained significant despite adjustments with AKI and two risk scores for mortality in cardiogenic shock.
CONCLUSIONS: High levels of P-PENK and P-NGAL at baseline were independently associated with AKI in cardiogenic shock patients. Furthermore, oliguria before study inclusion was associated with worse outcomes only if combined with high baseline levels of P-PENK or P-NGAL. High levels of both P-PENK and P-NGAL at 24 h were found to be strong and independent predictors of 90-day mortality.
TRIAL REGISTRATION: NCT01374867 at www.clinicaltrials.gov , registered 16 Jun 2011-retrospectively registered.
参考来源
- Jäntti T, Tarvasmäki T, Harjola VP, et al. Predictive value of plasma proenkephalin and neutrophil gelatinase-associated lipocalin in acute kidney injury and mortality in cardiogenic shock. Ann Intensive Care. 2021. PMID: 33547528. doi:10.1186/s13613-021-00814-8
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。